Home
Sotac Pharmaceuticals Ltd Quarterly Result

Sotac Pharmaceuticals Ltd
NSE: SotacPharma.
Net Profit - Last Quarter
Sotac Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Sotac Pharmaceuticals Ltd for the Sep '24 is ₹ 27.8 crore as compare to the Jun '24 revenue of ₹ 25.5 crore.
- This represent the growth of 9.02%a1# The ebitda of Sotac Pharmaceuticals Ltd for the Sep '24 is ₹ 2.56 crore as compare to the Jun '24 ebitda of ₹ 2.46 crore.
- This represent the growth of 4.07%a1# The net profit of Sotac Pharmaceuticals Ltd for the Sep '24 is ₹ 0.42 crore as compare to the Jun '24 net profit of ₹ 1.35 crore.
- This represent the decline of -68.89%a1#.
Sotac Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Sotac Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
19 Feb 2025 | 107.5 |
12 Feb 2025 | 104.75 |
06 Feb 2025 | 110.25 |
01 Feb 2025 | 105 |
28 Jan 2025 | 107 |
23 Jan 2025 | 110 |
17 Jan 2025 | 109.25 |
16 Jan 2025 | 115 |
14 Jan 2025 | 113.3 |
09 Jan 2025 | 108 |
Historical Revenue of Sotac Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Sotac Pharmaceuticals Ltd
Historical EBITDA of Sotac Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sotac Pharmaceuticals Ltd
Historical Net Profit of Sotac Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sotac Pharmaceuticals Ltd
Sotac Pharmaceuticals Ltd News Hub
Sotac Pharmaceuticals consolidated net profit rises 34.26% in the June 2024 quarter
Net profit of Sotac Pharmaceuticals rose 34.26% to Rs 1.45 crore in the quarter ended June 2024 as a
Read more
13 Aug 24
Sotac Pharmaceuticals to conduct board meeting
Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024
Read more
09 Aug 24
Sotac Pharmaceuticals AGM scheduled
Sotac Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be hel
Read more
30 Aug 24
Sotac Pharmaceuticals schedules board meeting
Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 October 202
Read more
26 Oct 24